New CMS Accountable Care Model Expected to Benefit Value-Based Care Providers
New ACO Model Introduction: CMS has announced the Long-term Enhanced ACO Design (LEAD) model, a 10-year voluntary pilot program starting in 2027, aimed at improving value-based care for healthcare providers.
Improvements Over Previous Model: LEAD addresses financial and administrative challenges faced by providers, offering enhanced cash flow payments and tools to better meet patient needs, particularly for high-needs patients.
Positive Industry Reaction: Jefferies has responded favorably to the LEAD model, indicating it provides future flexibility and stability for value-based care within Medicare fee-for-service.
Supporting Companies: Companies like Astrana Health, agilon health, and Privia Health Group are involved in supporting ACOs, with recent developments in their financial standings and market positions.
Trade with 70% Backtested Accuracy
Analyst Views on AGL
About AGL
About the author

- Klarna Class Action: A class action lawsuit against Klarna Group plc alleges that during its September 2025 IPO, the company failed to disclose the risk of increasing loss reserves, misleading investors about its business prospects, with a lead plaintiff deadline of February 20, 2026.
- agilon Health Lawsuit: The class action against agilon health, inc. claims that from February to August 2025, the company issued unrealistic financial guidance without disclosing significant industry headwinds, requiring investors to act by March 2, 2026.
- Fermi Inc. Litigation: Fermi Inc. faces a class action lawsuit alleging that from October to December 2025, it overstated tenant demand and relied heavily on a single tenant's funding commitment, with a lead plaintiff deadline of March 6, 2026.
- Legal Consultation Advice: Investors are encouraged to contact the Law Offices of Howard G. Smith to understand their legal rights in these class actions, highlighting the potential risks for the companies involved and the importance of investor rights protection.
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Agilon Health for violations of securities laws, concerning securities purchases between February 26, 2025, and August 4, 2025, with a deadline for participation set for March 2, 2026.
- False Statement Allegations: The complaint alleges that Agilon Health made false and misleading statements, overstating the impact of its strategic actions, which led to investor losses when the truth emerged, highlighting significant failures in the company's disclosure practices.
- Legal Proceedings Status: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, and those who do not act may become absent class members, potentially jeopardizing their claims.
- Investor Rights Protection: The Schall Law Firm specializes in securities class actions and encourages affected investors to reach out to discuss their rights, demonstrating a commitment to protecting investor interests.
- Legal Investigation Launched: Faruq & Faruqi LLP is investigating agilon health for potential securities violations related to trades made between February 26 and August 4, 2025, urging investors to apply as lead plaintiffs in a class action by the March 2, 2026 deadline to protect their rights.
- Financial Guidance Missteps: The company is accused of issuing unrealistic financial guidance for 2025 without adequately disclosing significant industry challenges, resulting in a 51.5% stock price drop on August 5, 2025, after the true situation was revealed, causing substantial investor losses.
- False Statement Allegations: The lawsuit claims that agilon and its executives made false and misleading statements in financial reports, failing to disclose the actual impact of their “strategic actions” on financial performance, which severely affected investor decision-making.
- Investor Rights Protection: Faruq & Faruqi encourages anyone with information, including former employees and shareholders, to contact them to support the investigation into agilon health, ensuring that investors' legal rights are upheld.
- Class Action Notice: The Gross Law Firm has issued a notice to shareholders of Agilon Health, encouraging those who purchased AGL shares between February 26, 2025, and August 4, 2025, to contact the firm regarding possible lead plaintiff appointment for potential recovery.
- Allegations of False Statements: The complaint alleges that during the class period, defendants made materially false and/or misleading statements and failed to disclose significant industry headwinds that would impact their 2025 guidance, misleading shareholders about the company's prospects.
- Overstated Financial Impact: Defendants are accused of materially overstating the immediate positive financial impact of strategic actions taken by Agilon, which misled shareholders and harmed their investment decisions.
- Registration Deadline: Shareholders must register by March 2, 2026, to participate in the class action, and upon registration, they will receive status updates throughout the case lifecycle, ensuring their rights are protected.
- Class Action Overview: The Law Offices of Frank R. Cruz remind investors that class action lawsuits have been filed against companies including agilon health, Fermi Inc., Varonis Systems, and Ardent Health, with deadlines for lead plaintiff motions approaching.
- agilon health Allegations: From February 26 to August 4, 2025, agilon health is accused of making materially false statements regarding its financial guidance, failing to disclose industry headwinds, which misled investors about the company's prospects, with a lead plaintiff deadline of March 2, 2026.
- Fermi Inc. Lawsuit Details: Fermi Inc. is charged with overstating tenant demand and the reliance on a single tenant's funding for its Project Matador from October 1 to December 11, 2025, with a lead plaintiff deadline of March 6, 2026.
- Varonis and Ardent Issues: Varonis is accused of being ill-equipped to sustain its ARR growth from February 4 to October 28, 2025, while Ardent is charged with failing to accurately assess the collectability of accounts receivable from July 18, 2024, to November 12, 2025, with lead plaintiff deadlines of March 9, 2026, for both companies.
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Agilon Health, Inc. on behalf of investors who purchased securities between February 26, 2025, and August 4, 2025, alleging that the company made false and misleading statements during this period, resulting in investor losses.
- Allegation Details: The lawsuit claims that Agilon executives issued unrealistic 2025 financial guidance despite being aware of significant industry challenges, and materially overstated the positive financial impact of their strategic actions, leading to a severely distorted view of the company's business and prospects among investors.
- Investor Rights: Affected investors must apply by March 2, 2026, to be appointed as lead plaintiffs in the lawsuit to protect their legal rights, with Bragar Eagel & Squire offering free consultations and encouraging investors to reach out for more information.
- Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in representing individual and institutional investors in securities, derivative, and commercial litigation, boasting extensive litigation experience and a nationwide practice.






